Rotavirus Vaccines-related Disease

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2019-10-14
Clinical Trial Update: Evaluation of Immunogenicity and Safety of Two Formulations of GSK Biologicals' Human Rotavirus (HRV) Vaccine (444563), in Healthy Infants Starting at Age 6-12 Weeks [Phase 3]
Phase 3 trial evaluating immunogenicity and safety of two formulations of GSK's human rotavirus vaccine in healthy infants; study completed …